Lundbeck

FDA approves ‘potential blockbuster’ migraine jab from Lundbeck

https://pharmaphorum.com/news/fda-approves-potential-blockbuster-migraine-jab-from-lundbeck/

Lundbeck’s digital strategy and how they manage global and local content

https://pharmaphorum.com/sales-marketing/lundbecks-digital-strategy-and-how-they-manage-global-and-local-content/

Lundbeck joins with Elsevier to help manage R&D data

https://pharmaphorum.com/news/lundbeck-joins-with-elsevier-to-help-manage-rd-data/

Lundbeck craters as resistant schizophrenia drug fails phase III

https://pharmaphorum.com/news/lundbeck-craters-as-resistant-schizophrenia-drug-fails-phase-iii/

Lundbeck brings third Parkinson’s drug into clinic

https://pharmaphorum.com/news/lundbeck-brings-third-parkinsons-drug-into-clinic/

Bad week for dementia R&D after Axovant howler and another failed trial

https://pharmaphorum.com/news/bad-week-dementia-rd-axovant-howler-another-failed-trial/

Swedish biotech Hansa shocked by CEO’s sudden death

https://pharmaphorum.com/news/swedish-biotech-hansa-rocked-ceos-sudden-death/

Lundbeck trial investigates genetic causes of depression

https://pharmaphorum.com/news/lundbeck-genetic-depression/

Lundbeck enlists IBM Watson to aid psychiatric drug research

https://pharmaphorum.com/news/lundbeck-ibm-watson-develop-new-psychiatric-medicines/

1 2

Close in 10 seconds

Pharmaphorum.com

Search